Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men
Drug concentrations associated with protection from HIV-1 acquisition have not been determined. We evaluated drug concentrations among men who have sex with men in a substudy of the iPrEx trial (1). In this randomized placebo-controlled trial, daily oral doses of emtricitabine/tenofovir disoproxil f...
Saved in:
Main Authors: | Anderson P., Glidden D., Liu A., Buchbinder S., Lama J., Guanira J., McMahan V., Bushman L., Casapía M., Montoya-Herrera O., Veloso V., Mayer K., Chariyalertsak S., Schechter M., Bekker L., Kallás E., Grant R. |
---|---|
Format: | Journal |
Published: |
2017
|
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84866283847&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/42774 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men
by: Peter L. Anderson, et al.
Published: (2018) -
The safety of tenofovir-emtricitabine for HIV pre-exposure prophylaxis (PrEP) in individuals with active hepatitis B
by: Solomon M., et al.
Published: (2017) -
Metabolic effects of preexposure prophylaxis with coformulated tenofovir disoproxil fumarate and emtricitabine
by: David V. Glidden, et al.
Published: (2018) -
Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis
by: Solomon M.M., et al.
Published: (2014) -
The safety of tenofovir-emtricitabine for HIV pre-exposure prophylaxis (PrEP) in individuals with active hepatitis B
by: Marc M. Solomon, et al.
Published: (2018)